¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 50(/LV1  
=V1k'XJ  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© G.O0*E2V  
l'VgS:NT  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© @<\f[Znt o  
L*9^-,  
1.Co-stimulators (or co-stimulating molecules) YcGSZ0vQ  
t(Cd oE,6  
2.NK-kB 4-=>># P  
` &|Rs  
3.Immunoglobulin superfamily : KZI+  
}3Pz{{B&+O  
4.antigen-presenting cell (APC) Fg?Gx(g4  
?};}#%971  
5.death domain 3`J?as@^8  
n w @cAv  
6.CCR and CXCR tz&=v,_jc  
H]Q Z4(  
7.Lectin (or mitogen) 0kpRvdEr-  
Et%s,zeA{2  
8.Clusters of differentiation, CD) O:RPH{D  
i=reJ(y-  
9.B7 family $uawQf+S  
HLAWx/c,j"  
10.Cytotoxic T lymphocyte, CTL) s9~W( Wi  
<m`HK.|~  
11.IL-15 and IL-15 receptor (IL-15R) }-)2CEj3L%  
S,lJ&Rsu  
12.MHC restriction [E2afC>zrl  
HW"|Hm$Y(  
13.Affinity-chromatography %z J)mOu  
{~k /xM.-  
14.Cyctosprin A, CsA $f*N  
nu}$wLM  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) O!lZ%j@%  
`&4L'1eF{  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© _$NFeqLww  
?7@B$OlU  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 c#$B;?  
>1,.4)k%K  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ A$WE:<^  
 VD;Ot<%  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ tjBs>w  
\$/)o1SG  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ixw3Z D(>+  
~urIA /  
ÃâÒßѧרҵ£º #gMMh B=  
CuR\JKdRo  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ *j?tcxq  
xM8}Xo  
Ïû»¯ÄÚ¿Æ£º xKWqDt  
T,@.RF  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 6B)(kPW  
h +.8Rl  
ѪҺ²¡Ñ§×¨Òµ£º od{Y` .<  
y{,HpPp#o  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
4+6=? ÕýÈ·´ð°¸:10
°´"Ctrl+Enter"Ö±½ÓÌá½»